Chairperson of the MS Swaminathan Research Foundation (MSSRF), Dr Soumya Swaminathan, has expressed concerns regarding the relationship between climate change and drug resistance.
Swaminathan, a former Chief Scientist at the World Health Organisation, expressed the concern in an interview.
She spoke on the sidelines of the WomenLift Health Global Conference 2024 in Dar es Salaam, Tanzania.
She gave insights into the complex relationship between the two global health issues and called for a multifaceted approach to mitigate their impacts.
Climate change refers to long-term shifts in the earth’s atmospheric conditions caused primarily by human activities such as burning fossil fuels and deforestation, leading to various environmental impacts.
ALSO READ: Noise pollution: Anambra warns nightclubs, industries
Drug resistance occurs when microorganisms develop the ability to survive previously effective drugs, posing challenges in healthcare by causing treatment failures and the spread of resistant strains.
Swaminathan highlighted various factors contributing to the rise in drug resistance, particularly in Tuberculosis (TB).
She said that improper prescriptions, self-medication, and overuse of antibiotics in healthcare settings were major contributors.
Additionally, she pointed out the widespread use of antibiotics in veterinary and agricultural practices leading to environmental contamination and the proliferation of resistant bacteria.
On the connection between climate change and antimicrobial resistance, she said that rising temperatures and changing climate patterns could create favorable conditions for the spread of infectious diseases and the emergence of drug-resistant strains.
She urged the adoption of a One Health approach, which recognizes the interconnectedness of human, animal, and environmental health in addressing the challenges.
ALSO READ: Tinubu pledges partnership with Jamaica on climate change, energy transition
She said that there was an urgent need for coordinated global and national efforts to combat drug resistance and mitigate the impact of climate change on health.
She called for the development of standards and guidelines at both levels to regulate the use of antibiotics, strengthen healthcare systems, and enhance surveillance and response mechanisms for infectious diseases.
The researcher urged sustained investment in health infrastructure, workforce training, and research to build resilient health systems capable of responding effectively to emerging threats.
She also stressed the importance of domestic financing for health, while advocating for continued international support, particularly for low and middle-income countries facing resource constraints.
NAN
